These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32574621)

  • 1. Human Plasminogen Exacerbates Clostridioides difficile Enteric Disease and Alters the Spore Surface.
    Awad MM; Hutton ML; Quek AJ; Klare WP; Mileto SJ; Mackin K; Ly D; Oorschot V; Bosnjak M; Jenkin G; Conroy PJ; West N; Fulcher A; Costin A; Day CJ; Jennings MP; Medcalf RL; Sanderson-Smith M; Cordwell SJ; Law RHP; Whisstock JC; Lyras D
    Gastroenterology; 2020 Oct; 159(4):1431-1443.e6. PubMed ID: 32574621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal Immunization with the C-Terminal Domain of Bcla3 Induced Specific IgG Production and Attenuated Disease Symptoms in Mice Infected with
    Maia AR; Reyes-Ramírez R; Pizarro-Guajardo M; Saggese A; Ricca E; Baccigalupi L; Paredes-Sabja D
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933117
    [No Abstract]   [Full Text] [Related]  

  • 3. Muricholic acids inhibit Clostridium difficile spore germination and growth.
    Francis MB; Allen CA; Sorg JA
    PLoS One; 2013; 8(9):e73653. PubMed ID: 24040011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile infection: molecular pathogenesis and novel therapeutics.
    Rineh A; Kelso MJ; Vatansever F; Tegos GP; Hamblin MR
    Expert Rev Anti Infect Ther; 2014 Jan; 12(1):131-50. PubMed ID: 24410618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualization of fidaxomicin association with the exosporium layer of Clostridioides difficile spores.
    Bassères E; Endres BT; Montes-Bravo N; Pérez-Soto N; Rashid T; Lancaster C; Begum K; Alam MJ; Paredes-Sabja D; Garey KW
    Anaerobe; 2021 Jun; 69():102352. PubMed ID: 33640461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic treatment of clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts.
    Lawley TD; Clare S; Walker AW; Goulding D; Stabler RA; Croucher N; Mastroeni P; Scott P; Raisen C; Mottram L; Fairweather NF; Wren BW; Parkhill J; Dougan G
    Infect Immun; 2009 Sep; 77(9):3661-9. PubMed ID: 19564382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging Clostridioides difficile Spore Germination and Germination Proteins.
    Baloh M; Nerber HN; Sorg JA
    J Bacteriol; 2022 Jul; 204(7):e0021022. PubMed ID: 35762766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping interactions between germinants and Clostridium difficile spores.
    Howerton A; Ramirez N; Abel-Santos E
    J Bacteriol; 2011 Jan; 193(1):274-82. PubMed ID: 20971909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oritavancin does not induce Clostridium difficile germination and toxin production in hamsters or a human gut model.
    Freeman J; Marquis M; Crowther GS; Todhunter SL; Fawley WN; Chilton CH; Moeck G; Lehoux D; Wilcox MH
    J Antimicrob Chemother; 2012 Dec; 67(12):2919-26. PubMed ID: 22899803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infection.
    Srikhanta YN; Hutton ML; Awad MM; Drinkwater N; Singleton J; Day SL; Cunningham BA; McGowan S; Lyras D
    Nat Microbiol; 2019 Dec; 4(12):2237-2245. PubMed ID: 31406331
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Diaz OR; Sayer CV; Popham DL; Shen A
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29950380
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantifying bacterial spore germination by single-cell impedance cytometry for assessment of host microbiota susceptibility to Clostridioides difficile infection.
    Moore JH; Salahi A; Honrado C; Warburton C; Warren CA; Swami NS
    Biosens Bioelectron; 2020 Oct; 166():112440. PubMed ID: 32745926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile salts and glycine as cogerminants for Clostridium difficile spores.
    Sorg JA; Sonenshein AL
    J Bacteriol; 2008 Apr; 190(7):2505-12. PubMed ID: 18245298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
    Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW
    Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections.
    Yip C; Okada NC; Howerton A; Amei A; Abel-Santos E
    Biochem Pharmacol; 2021 Jan; 183():114314. PubMed ID: 33152344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an Endolysin Targeting
    Mondal SI; Akter A; Draper LA; Ross RP; Hill C
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073633
    [No Abstract]   [Full Text] [Related]  

  • 17. Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination.
    Sorg JA; Sonenshein AL
    J Bacteriol; 2009 Feb; 191(3):1115-7. PubMed ID: 19060152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic and genomic characterization of highly infectious Clostridium difficile 630 spores.
    Lawley TD; Croucher NJ; Yu L; Clare S; Sebaihia M; Goulding D; Pickard DJ; Parkhill J; Choudhary J; Dougan G
    J Bacteriol; 2009 Sep; 191(17):5377-86. PubMed ID: 19542279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of an oral suspension of VP20621, spores of nontoxigenic Clostridium difficile strain M3, in healthy subjects.
    Villano SA; Seiberling M; Tatarowicz W; Monnot-Chase E; Gerding DN
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5224-9. PubMed ID: 22850511
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Shen A
    Annu Rev Microbiol; 2020 Sep; 74():545-566. PubMed ID: 32905755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.